Gedeon Richter Pharmaceuticals Company is a Hungarian-controlled Central-Eastern European multinational pharmaceutical company. The parent company and its manufacturing subsidiaries in four countries combine to form the region's leading pharmaceutical manufacturing group. The Company’s products are available, through its own distribution network, to the inhabitants of some 100 different countries.

Richter blends its hundred-year tradition of pharmaceutical manufacturing in Hungary with state-of-the-art technology. The Company's mission is to improve standards of healthcare by supplying modern and affordable products.

A key factor in the Company’s success is its pool of experience and expertise, accumulated over more than a century. Today, Richter has not only succeeded in retaining its leading position in the domestic market, but has evolved into a Central-Eastern European multinational corporation, with a growing presence in the CIS nations, the European Union and the USA.

Original pharmaceutical molecular research and unceasing innovation have been defining elements of Richter's strategy since its establishment in 1901. Today, with an 800-strong research and development team, the Company has evolved into the Central-Eastern European region’s most important centre for pharmaceutical research.

Besides carrying out original research, the Company is also engaged in the development of generic drugs and chemical processes. Our original pharmaceutical research activities focus exclusively on the identification of active ingredients that are effective in the treatment of diseases of the central nervous system, primarily molecules that are suitable for the alleviation of chronic pain, schizophrenia and anxiety.

Click to visit www.richter.hu